Your session is about to expire
← Back to Search
This trial will compare deep vs moderate neuromuscular blockade in men undergoing robotic prostate surgery to see if there is a difference in post-surgery pain.
- Prostate Cancer
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- Group 1: Interventional Group: Deep Neuromuscular Blockade
- Group 2: Control Group: Moderate Neuromuscular Blockade
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
In what situations is Rocuronium 1.5mg/kg/hr most prescribed?
"intubation (procedure), muscular fasciculation, and curarization therapy can all be effectively treated by using Rocuronium 1.5mg/kg/hr."
Are there any previous instances of Rocuronium 1.5mg/kg/hr being used in research?
"Currently, there are 16 ongoing studies evaluating the effects of Rocuronium 1.5mg/kg/hr with 3 Phase 3 trials underway. Of the 29 total clinical trial sites for Rocuronium 1.5mg/kg/hr, several are based in Montreal, Quebec."
What makes this particular trial innovative or unique?
"Data shows that there are 16 different ongoing clinical trials for Rocuronium 1.5mg/kg/hr in 11 cities and 10 countries. The first ever trial of its kind was completed in 2009 by Medtronic - MITG. That particular study had 80 participants and finished its N/A drug approval stage. In the last 12 years, 135 similar trials have been conducted."
Are there any specific inclusion criteria for this research?
"This particular clinical trial is looking for 130 patients that have prostate cancer and are between 18-80 years old. Other requirements include being an adult under 80 years old who will be undergoing surgery at Josie Robertson Surgical Center."
Could you please highlight any potential dangers of Rocuronium 1.5mg/kg/hr for patients?
"Rocuronium 1.5mg/kg/hr is estimated to be a 2 in terms of safety by our team because it is in Phase 2 of clinical trials. This lack of efficacy data means that, while some safety data exists, there is none to support its use as an effective medication."
How many people are being signed up for this experiment?
"Yes, according to the information displayed on clinicaltrials.gov, this study is still recruiting patients. The trial was originally posted on 1/14/2019 and was last updated on 7/12/2022. Currently, the research team is looking for 130 individuals who are willing to participate at one of two locations."
Does this test case allow for elderly patients?
"The age limit for this particular clinical trial is 18 to 80 years old. There are a total of 85 trials for patients that meet the under-18 criteria and 1,371 trials for people who exceed 65 years of age."
Are patients currently being accepted for this trial period?
"Yes, as the clinicaltrials.gov website reports, this trial is open and actively recruiting participants. The study was posted on January 14th, 2019 and was last edited on July 12th, 2022."
Share this study with friends